Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon.
Niba PTN, Nji AM, Chedjou JPK, Hansson H, Hocke EF, Ali IM, Achonduh-Atijegbe O, Evehe MB, Jørgensen MHM, Fomboh CT, Cui L, Stresman G, Bigoga JD, Alifrangis M, Mbacham WF. Niba PTN, et al. Int J Infect Dis. 2023 Jul;132:108-117. doi: 10.1016/j.ijid.2023.03.050. Epub 2023 Apr 6. Int J Infect Dis. 2023. PMID: 37028468 Free PMC article.
Allelic frequencies of mutants of the Plasmodium falciparum, quinoline and folate metabolizing genes in the west region of Cameroon.
Ali IM, Tchuenkam VPK, Tagomo SS, Mawamba H, Moyeh MN, Nfor EN, Nji AM, Fomboh CT, Nana WD, Kengne JC, Niba PTN, Ekoyol GE, Achu DF, Bigoga JD, Mbacham WF. Ali IM, et al. Among authors: niba ptn. Heliyon. 2022 Nov 23;8(11):e11861. doi: 10.1016/j.heliyon.2022.e11861. eCollection 2022 Nov. Heliyon. 2022. PMID: 36451747 Free PMC article.
Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
Niba PTN, Nji AM, Ali IM, Akam LF, Dongmo CH, Chedjou JPK, Fomboh CT, Nana WD, Oben OLA, Selly-Ngaloumo AA, Moyeh MN, Ngu JA, Ludovic AJ, Aboh PM, Ambani MCE, Omgba PAM, Kotcholi GB, Adzemye LM, Nna DRA, Douanla A, Ango Z, Ewane MS, Ticha JT, Tatah FM, Dinza G, Ndikum VN, Fosah DA, Bigoga JD, Alifrangis M, Mbacham WF. Niba PTN, et al. BMC Infect Dis. 2022 Feb 21;22(1):166. doi: 10.1186/s12879-022-07101-2. BMC Infect Dis. 2022. PMID: 35189818 Free PMC article. Clinical Trial.
Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998-2020).
Niba PTN, Nji AM, Evehe MS, Ali IM, Netongo PM, Ngwafor R, Moyeh MN, Ngum LN, Ndum OE, Acho FA, Mbu'u CM, Fosah DA, Atogho-Tiedeu B, Achonduh-Atijegbe O, Djokam-Dadjeu R, Chedjou JPK, Bigoga JD, Moukoko CEE, Ajua A, Achidi E, Tallah E, Leke RGF, Tourgordi A, Ringwald P, Alifrangis M, Mbacham WF. Niba PTN, et al. Malar J. 2021 Jan 9;20(1):32. doi: 10.1186/s12936-020-03543-8. Malar J. 2021. PMID: 33422080 Free PMC article.